These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 11083532

  • 1. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.
    Eur J Nucl Med; 2000 Oct; 27(10):1441-56. PubMed ID: 11083532
    [Abstract] [Full Text] [Related]

  • 2. Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.
    Keith CJ, Miles KA, Griffiths MR, Wong D, Pitman AG, Hicks RJ.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1016-23. PubMed ID: 12173015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.
    Eur J Nucl Med; 2000 Nov; 27(11):1598-609. PubMed ID: 11105815
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
    Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.
    Ann Intern Med; 2003 May 06; 138(9):724-35. PubMed ID: 12729427
    [Abstract] [Full Text] [Related]

  • 6. Is FDG PET/CT cost-effective for pre-operation staging of potentially operative non-small cell lung cancer? - From Chinese healthcare system perspective.
    Wang YT, Huang G.
    Eur J Radiol; 2012 Aug 06; 81(8):e903-9. PubMed ID: 22698711
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.
    Comber LA, Keith CJ, Griffiths M, Miles KA.
    Clin Radiol; 2003 Sep 06; 58(9):706-11. PubMed ID: 12943643
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of initial diagnostic strategies for pulmonary nodules presenting to thoracic surgeons.
    Deppen SA, Davis WT, Green EA, Rickman O, Aldrich MC, Fletcher S, Putnam JB, Grogan EL.
    Ann Thorac Surg; 2014 Oct 06; 98(4):1214-22. PubMed ID: 25087933
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.
    Scott WJ, Shepherd J, Gambhir SS.
    Ann Thorac Surg; 1998 Dec 06; 66(6):1876-83; discussion 1883-5. PubMed ID: 9930463
    [Abstract] [Full Text] [Related]

  • 14. Medical economics of whole-body FDG PET in patients suspected of having non-small cell lung carcinoma--reassessment based on the revised Japanese national insurance reimbursement system.
    Abe K, Kosuda S, Kusano S.
    Ann Nucl Med; 2003 Dec 06; 17(8):649-55. PubMed ID: 14971606
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?
    Spadafora M, Evangelista L, Gridelli C, Cuocolo A.
    Eur J Radiol; 2017 May 06; 90():188-191. PubMed ID: 28583632
    [Abstract] [Full Text] [Related]

  • 17. [Whether and under what conditions FDG-PET might be cost-effective in evaluating solitary pulmonary nodules depicted on lung cancer screening in Japan].
    Tsushima Y, Aoki J, Endo K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2003 Sep 06; 63(8):390-8. PubMed ID: 14587408
    [Abstract] [Full Text] [Related]

  • 18. Analytical decision model for the cost-effective management of solitary pulmonary nodules.
    Gambhir SS, Shepherd JE, Shah BD, Hart E, Hoh CK, Valk PE, Emi T, Phelps ME.
    J Clin Oncol; 1998 Jun 06; 16(6):2113-25. PubMed ID: 9626211
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.